Resources

Welcome to our searchable resource and literature collection on safer supply and related topics.

Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.

 

Peer Engagement Principles and Best Practices: A Guide for BC Health Authorities and Other Providers, version 2

Peers can provide insights into the realities of substance use and their local risk environments, and the applicability of programs and policies.
Guidelines | 2018
Equity, Peer/PWLLE program involvement

Safer Opioid Supply Programs (SOS): A Harm Reduction Informed Guiding Document for Primary Care Teams

Despite a current lack of direct evidence, this document has been created to urgently combat overdose deaths. It is informed by existing research and based out of expert opinion.
Guidelines | 2020
Mortality, Clinical guidance, Harm reduction, Safer supply, About prescribers, Transitions in care/treatment, Injecting drugs, Diversion

Substance Replacement Therapy in the Context of the COVID-19 Pandemic in Québec: Clinical Guidance for Prescribers

Quebec safe supply clinical guidance for prescribers
Guidelines | 2020
Overdose, Clinical guidance, Harm reduction, Safer supply, About prescribers, Stimulants, Substitution/OAT, Transitions in care/treatment, Injecting drugs

National Injectable Opioid Agonist Treatment Guideline

The clinical guideline was developed to provide key clinical recommendations, as well as clinical guidance on the provision of iOAT.
Guidelines | 2019
Clinical guidance, Policy/Regulatory, Safer supply, About prescribers, Illegal drugs, Stimulants, Transitions in care/treatment, Injecting drugs

Guidance for Injectable Opiod Agonist Treatment for Opioid Use Disorder

Guidelines | 2017
Clinical guidance, Evidence base, Policy/Regulatory, About prescribers

Guideline for the Clinical Management of Opioid Use Disorder

Guidelines | 2023
Clinical guidance, Policy/Regulatory, About prescribers

Peer Payment Standards for Short-Term Engagements

Created in collaboration with peers and providers
Guidelines | 2018
About prescribers, About PWUD, Workplace, Peer/PWLLE program involvement

Risk Mitigation in the Context of Dual Public Health Emergencies

BC safe suply interim guidance for safe supply/COVID-19 risk mitigation during the pandemic

Guidelines | 2022
Overdose, Clinical guidance, Harm reduction, Safer supply, About prescribers, Rural/remote, Substitution/OAT, Carries/take-home doses

Supervised Consumption Services: Operational Guidance

Guidelines | 2017
Clinical guidance, Policy/Regulatory, About prescribers, SCS/OPS

Harm Reduction at Work: A Guide for Organizations Employing People Who Use Drugs

The key goal of this guide is to help harm reduction organizations and drug policy advocates hire and work with active drug users

Guidelines | 2010
Policy/Regulatory, About PWUD, Workplace, Substitution/OAT, Peer/PWLLE program involvement, Harm reduction

Recommendations on Chronic Pain Practice during the COVID-19 Pandemic

This resource provides information and recommendations to chronic pain practitioners and patients during the COVID-19 pandemic.
Guidelines | 2020
Withdrawal, Clinical guidance, Harm reduction, About prescribers, Chronic pain

Refine Your Search

Keywords
Format
Region